Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenpu Granules
- Development stage
- Unknown
- Lead developer
- Jiangsu Kanion Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shenpu Granules (also known as 参蒲颗粒 or Shenpu Pen'an Granules) is a Class 1.1 innovative traditional Chinese medicine (TCM) developed by Kanion Pharmaceutical. It was approved by China's National Medical Products Administration (NMPA) on July 31, 2025, for the treatment of chronic pelvic pain caused by sequelae of pelvic inflammatory disease (PID), which is classified under the TCM syndrome of dampness-heat and blood stasis obstruction. The formulation is a multi-herb granule preparation derived from a clinical experience prescription of Professor Tan Yong from the Affiliated Hospital of Nanjing University of Chinese Medicine. It consists of several herbal ingredients, including Codonopsis pilosula (Dangshen), Sargentodoxa cuneata (Daxueteng), Taraxacum mongolicum (Pugongying / Dandelion), Smilax china (Baqia), Gleditsia sinensis spine (Zaojiaci), Polygonum cuspidatum (Huzhang), Paeonia lactiflora (Chishao / Red Peony Root), Corydalis yanhusuo (Yanhusuo), Salvia miltiorrhiza (Danshen), and Lindera aggregata (Wuyao). In TCM theory, Shenpu Granules functions to replenish qi, activate blood circulation, clear dampness and heat, and unblock collaterals to relieve pain.
- Brand names
- Shenpu Granules参蒲颗粒
- Other names
- Shenpu Pen'an GranulesShenpu Penyan GranulesShenpu Penyanke Granules参蒲盆安颗粒参蒲盆炎颗粒神蒲颗粒
Beyond the preview
Go deeper on Shenpu Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenpu Granules.